Search for Clinical Trial Results
Neurofibromatosis 2 - 25 Studies Found
Status | Study |
Completed |
Study Name: Endostatin Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors Condition:
Date: 2014-03-26 Interventions: Drug: Endostatin Method of drug administration:continuous intravenous pumping; Dosage: 7.5mg/m2/d; Cours |
Recruiting |
Study Name: Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas Condition:
Date: 2014-04-29 Interventions: Drug: Axitinib Other Name: Inlyta |
Recruiting |
Study Name: Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma Condition:
Date: 2011-04-21 Interventions: Drug: RAD001, everolimus Adults: 10 mg p.o. daily dose, age 16 - 17: 3.0 mg/m2 p.o. daily |
No longer available |
Study Name: Compassionate Use Arm - ABI541 ABI for 10 NF2 Patients Condition:
|
Completed |
Study Name: Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2) Condition:
Date: 2010-09-01 Interventions:
|
Completed |
Study Name: NF2 Natural History Consortium Condition:
|
Recruiting |
Study Name: Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors Condition:
Date: 2010-10-15 |
Recruiting |
Study Name: Neurofibromatosis (NF) Registry Portal Condition:
|